Low serum vitamin D level is associated with high risk of metabolic syndrome in post-menopausal women

Journal of Endocrinological Investigation

Volumn 36, Issue 10, 2013, Pages 791-796

  Song, H R ^a   Park, C H ^b,c  

^a Seoul National University   (South Korea)

^b Chungbuk National University College of Medicine   (South Korea)

^c Eulji University   (South Korea)

Author keywords

Abdominal obesity; Hypertension; Impaired fasting glucose; Metabolic syndrome; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; TRIACYLGLYCEROL;

ADULT; ARTICLE; ASIAN; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ELEVATED BLOOD PRESSURE; FEMALE; HEALTH CENTER; HEALTH PROMOTION; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MIDDLE AGED; POSTMENOPAUSE; UNIVERSITY HOSPITAL; VITAMIN BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POSTMENOPAUSE; PROGNOSIS; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84891693347     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/BF03346758     Document Type: Article

References (38)

1. Holick MF. Vitamin D deficiency. N Engl J Med 2007, 357: 266-81.
2. Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 2003, 17: 509-11.
3. Simpson RU, Thomas GA, Arnold AJ. Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem 1985, 260: 8882-91.
4. Pinelli NR, Jaber LA, Brown MB, Herman WH. Serum 25-hydroxy vitamin d and insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans. Diabetes Care 2010, 33: 1373-5.
5. Mattila C, Knekt P, Männistö S, et al. Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 2007, 30: 2569-70.
6. Choi HS, Kim KA, Lim CY, et al. Low serum vitamin D is associated with high risk of diabetes in Korean adults. J Nutr 2011, 141: 1524-8.
7. Wilson PW, Garrison RJ, Castelli WP, Feinleib M, McNamara PM, Kannel WB. Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols. Am J Cardiol 1980, 46: 649-54.
8. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984, 251: 351-64.
9. He J, Gu D, Wu X, et al. Major causes of death among men and women in China. N Engl J Med 2005, 353: 1124-34.
10. Reddy KS. Cardiovascular disease in non-Western countries. N Engl J Med 2004, 350: 2438-40.
11. Mosekilde L. Vitamin D and the elderly. Clin Endocrinol (Oxf) 2005, 62: 265-81.
12. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120: 1640-5.
13. Lee SY, Park HS, Kim DJ, et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 2007, 75: 72-80.
14. Park HS, Park CY, Oh SW, Yoo HJ. Prevalence of obesity and metabolic syndrome in Korean adults. Obes Rev 2008, 9: 104-7.
15. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006, 84: 18-28.
16. Choi HS, Oh HJ, Choi H, et al. Vitamin D insufficiency in Korea - a greater threat to younger generation: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008. J Clin Endocrinol Metab 2011, 96: 643-51.
17. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005, 28: 1228-30.
18. Hypponen E, Boucher BJ, Berry DJ, Power C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 2008, 57: 298-305.
19. Cheng S, Massaro JM, Fox CS, et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes 2010, 59: 242-8.
20. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004, 79: 820-5.
21. Lu L, Yu Z, Pan A, et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 2009, 32: 1278-83.
22. Moy FM, Bulgiba A. High prevalence of vitamin D insufficiency and its association with obesity and metabolic syndrome among Malay adults in Kuala Lumpur, Malaysia. BMC Public Health 2011, 11: 735.
23. Rueda S, Fernandez-Fernandez C, Romero F, Martinez de Osaba J, Vidal J. Vitamin D, PTH, and the metabolic syndrome in severely obese subjects. Obes Surg 2008, 18: 151-4.
24. Reis JP, von Muhlen D, Kritz-Silverstein D, Wingard DL, Barrett-Connor E. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 2007, 30: 1549-55.
25. Looker AC. Body fat and vitamin D status in black versus white women. J Clin Endocrinol Metab 2005, 90: 635-40.
26. Awumey EM, Mitra DA, Hollis BW, Kumar R, Bell NH. Vitamin D metabolism is altered in Asian Indians in the southern United States: a clinical research center study. J Clin Endocrinol Metab 1998, 83: 169-73.
27. Bland R, Markovic D, Hills CE, et al. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 2004, 89-90: 121-5.
28. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007, 92: 2017-29.
29. Ginsberg HN, Zhang YL, Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res 2005, 36: 232-40.
30. Kim MK, Il Kang M, Won Oh K, et al. The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects. Clin Endocrinol (Oxf) 2010, 73: 330-8.
31. Burgess ED, Hawkins RG, Watanabe M. Interaction of 1,25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension. Am J Hypertens 1990, 3: 903-5.
32. Li YC, Kong J, Wei M, Chen ZF, Liu SQ,Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002, 110: 229-38.
33. Duque G, El Abdaimi K, Macoritto M, Miller MM, Kremer R. Estrogens (E2) regulate expression and response of 1,25-dihydroxyvitamin D3 receptors in bone cells: changes with aging and hormone deprivation. Biochem Biophys Res Commun 2002, 299: 446-54.
34. Pattanaungkul S, Riggs BL, Yergey AL, Vieira NE, O'Fallon WM, Khosla S. Relationship of intestinal calcium absorption to 1,25-dihydroxyvitamin D [1,25(OH)2D] levels in young versus elderly women: evidence for age-related intestinal resistance to 1,25(OH)2D action. J Clin Endocrinol Metab 2000, 85: 4023-7.
35. Scopacasa F, Wishart JM, Horowitz M, Morris HA, Need AG. Relation between calcium absorption and serum calcitriol in normal men: evidence for age-related intestinal resistance to calcitriol. Eur J Clin Nutr 2004, 58: 264-9.
36. Dusso AS. Vitamin D receptor: mechanisms for vitamin D resistance in renal failure. Kidney Int Suppl 2003, 85: S6-9.
37. Marjani A, Moghasemi S. Serum vitamin D and metabolic syndrome among postmenopausal women in Gorgan. Biomed Res 2012, 23: 275-80.
38. Reis JP, von Mühlen D, Miller ER 3rd. Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol 2008, 159: 41-8.